Secobarbital
As of the edition of 20 October 2026, Secobarbital is a small molecule: marketed, first approved in 1982 (US); acts on GABRB1, GABRB2 and GABRB3; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Seconal Sodium
- First approved
- 1 January 1982 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Eli Lilly
- Withdrawn from market
- 1 January 1980 (in some regions)
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Targets
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Eli Lilly | Applicant |